Home
»
Race to Commercialize Biotechnology
A01=Steven Collins
Author_Steven Collins
Bayh Dole Act
Biotechnology Firms
Biotechnology Products
Category=GTM
Category=JP
Category=KND
Commercial Biotechnology
Dedicated Biotechnology Companies
Dedicated Biotechnology Firm
dna
eq_bestseller
eq_business-finance-law
eq_isMigrated=1
eq_isMigrated=2
eq_nobargain
eq_non-fiction
eq_society-politics
Federal Bureau Of Investigation
Fermentation Technology
firms
Genetically Modified
innovation
Intellectual Property Protection Regimes
Japan's Pharmaceutical Industry
japanese
Japanese Firms
Japan’s Pharmaceutical Industry
Kyowa Hakko
Meiji Seika
Metastatic Breast Cancer
MHLW
MITI
national
NIH Guideline
Nis
processes
Public Research Institutes
recombinant
Recombinant DNA
regime
Soy Bean Curd
system
technological
Technological Regime
Technological Trajectory
West Germany
Product details
- ISBN 9780415283397
- Weight: 540g
- Dimensions: 156 x 234mm
- Publication Date: 25 Mar 2004
- Publisher: Taylor & Francis Ltd
- Publication City/Country: GB
- Product Form: Hardback
Delivery/Collection within 10-20 working days
Our Delivery Time Frames Explained
2-4 Working Days: Available in-stock
10-20 Working Days: On Backorder
Will Deliver When Available: On Pre-Order or Reprinting
We ship your order once all items have arrived at our warehouse and are processed. Need those 2-4 day shipping items sooner? Just place a separate order for them!
This comparative study looks at the early development of biotechnology in the US and Japan. Drawing on primary and secondary sources it traces the historical roots of recombinant DNA technology, discusses the tensions between regulation and promotional policies and identifies the major actors and strategies that launched biotechnology in both countries. Developing several strands of theory in economic history, science and technology policy, the book proposes a simple model that relates the differences in the two countries' responses to variations in the availability of institutional, financial and organizational resources needed to commercialize the new technology.
Steven W. Collins is Associate Professor in the Interdisciplinary Arts and Sciences Program at the University of Washington.
Qty:
